Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
neoX Biotech closes US$30 million Series A round 2021-02-09 21:28
Regent Pacific's Strategic Partner Obtains Clinical Trial Approval for FORTACIN(TM) 2021-02-09 20:35
Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China 2021-02-09 20:00
Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Explore the Oncology Market in China 2021-02-09 08:30
The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics 2021-02-09 08:25
Innovent Announces First Patient Dosed in Phase III Pivotal Trial of IBI310 (CTLA-4) Combined with TYVYT® (sintilimab injection) for the Treatment of First-line Advanced Hepatocellular Carcinoma 2021-02-09 08:00
Inova Appoints Claude Basset as Chief Product Officer 2021-02-08 16:00
Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II) 2021-02-08 15:00
Sihuan Pharmaceutical (0460.HK) The sole agent of Letybo 100U China AI Listing Conference was successfully held 2021-02-05 11:32
Global survey presented at the Digital Liver Cancer Summit 2021 reveals heavy toll of COVID-19 first wave on liver cancer care 2021-02-05 07:00
Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries 2021-02-04 20:30
Vemlidy(r) Demonstrates Continued Efficacy and Improved Safety for Asian Patients with Hepatitis B 2021-02-04 12:00
FDA Approves TEPMETKO® as the First and Only Once-daily Oral MET Inhibitor for Patients with Metastatic NSCLC with METex14 Skipping Alterations 2021-02-04 02:57
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Pemetrexed and Platinum Chemotherapy as First-Line Therapy for Nonsquamous Non-Small Cell Lung Cancer 2021-02-03 12:30
Elekta's MOSAIQ and Versa HD earn top honors in 2021 Best in KLAS: Software and Services Report 2021-02-03 00:30
Kira Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial for P014, a Bifunctional Biologic Medicine 2021-02-02 20:00
Ascentage Pharma Released Preclinical Results of MDM2-p53 Inhibitor APG-115 in an Oral Presentation at WCLC 2020, Demonstrating Therapeutic Potential in STK11-Mutant Non-Small Cell Lung Cancer 2021-02-02 17:24
Globally unique MRI Guarantee: The highest MRI safety with hearing implants from MED-EL 2021-02-02 15:00
Inmagene launched U.S. subsidiary; Dr. Jean-Louis Saillot joined the company. 2021-02-02 14:48
CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today's Global Release of the "R Plus Health" Free App 2021-02-02 09:00
1 135 136 137 138 139 234